Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
12.30
+1.12 (10.02%)
At close: Mar 9, 2026, 4:00 PM EDT
12.06
-0.24 (-1.93%)
After-hours: Mar 9, 2026, 7:54 PM EDT
Korro Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 116 | 357 | 383 | - | - |
| Market Cap Growth | -56.84% | -6.96% | - | - | - |
| Enterprise Value | 58 | 229 | 578 | - | - |
| Last Close Price | 12.30 | 38.07 | 47.93 | - | - |
| PS Ratio | 15.71 | 157.04 | - | - | - |
| PB Ratio | 1.17 | 2.22 | 2.26 | - | - |
| P/TBV Ratio | 1.17 | 2.22 | 2.26 | - | - |
| EV/Sales Ratio | 7.87 | 100.98 | - | - | - |
| Debt / Equity Ratio | 0.45 | 0.28 | 0.20 | 0.05 | - |
| Net Debt / Equity Ratio | -0.58 | -0.74 | -0.78 | -0.80 | -0.97 |
| Net Debt / EBITDA Ratio | 0.65 | 1.34 | 1.64 | 0.92 | 3.50 |
| Net Debt / FCF Ratio | 0.82 | 1.52 | 1.77 | 0.89 | 3.24 |
| Asset Turnover | 0.04 | 0.01 | - | - | - |
| Quick Ratio | 6.37 | 8.54 | 8.53 | 6.35 | 23.95 |
| Current Ratio | 6.71 | 8.79 | 8.87 | 6.56 | 24.20 |
| Return on Equity (ROE) | -63.46% | -50.60% | -69.16% | -62.24% | - |
| Return on Assets (ROA) | -29.16% | -25.65% | -35.77% | -36.63% | - |
| Return on Capital Employed (ROCE) | -64.30% | -43.50% | -41.80% | -90.70% | -28.90% |
| Earnings Yield | -76.33% | -23.43% | -21.18% | - | - |
| FCF Yield | -60.64% | -21.86% | -19.60% | - | - |
| Buyback Yield / Dilution | -18.78% | -483.30% | -499.32% | 94.26% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.